Follow
Ananth Ravi
Ananth Ravi
MOLLI Surgical & Sunnybrook Odette Cancer Centre
Verified email at mollisurgical.com
Title
Cited by
Cited by
Year
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction …
JM Hudson, A Loblaw, M McGuffin, HT Chung, CL Tseng, J Helou, ...
Radiotherapy and Oncology, 110381, 2024
1292024
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II …
G Morton, HT Chung, M McGuffin, J Helou, L D’Alimonte, A Ravi, ...
Radiotherapy and Oncology 122 (1), 87-92, 2017
942017
System and method for magnetic occult lesion localization and imaging
A Ravi, J Dillon
US Patent 11,291,384, 2022
762022
Evaluation of a machine-learning algorithm for treatment planning in prostate low-dose-rate brachytherapy
A Nicolae, G Morton, H Chung, A Loblaw, S Jain, D Mitchell, L Lu, J Helou, ...
International Journal of Radiation Oncology* Biology* Physics 97 (4), 822-829, 2017
742017
Electromagnetic tracking for catheter reconstruction in ultrasound-guided high-dose-rate brachytherapy of the prostate
S Bharat, C Kung, E Dehghan, A Ravi, N Venugopal, A Bonillas, ...
Brachytherapy 13 (6), 640-650, 2014
732014
Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomized trial
HC Quon, A Ong, P Cheung, W Chu, HT Chung, D Vesprini, A Chowdhury, ...
Radiotherapy and Oncology 127 (2), 206-212, 2018
652018
Doses to internal organs for various breast radiation techniques-implications on the risk of secondary cancers and cardiomyopathy
JP Pignol, BM Keller, A Ravi
Radiation oncology 6, 1-6, 2011
652011
High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of success
J Helou, L D’Alimonte, A Loblaw, H Chung, P Cheung, E Szumacher, ...
Radiotherapy and Oncology 115 (1), 84-89, 2015
642015
Focal salvage high dose-rate brachytherapy for locally recurrent prostate cancer after primary radiation therapy failure: results from a prospective clinical trial
J Murgic, G Morton, A Loblaw, L D'Alimonte, A Ravi, M Wronski, ...
International Journal of Radiation Oncology* Biology* Physics 102 (3), 561-567, 2018
622018
Direction-modulated brachytherapy for high-dose-rate treatment of cervical cancer. I: Theoretical design
DY Han, MJ Webster, DJ Scanderbeg, C Yashar, D Choi, B Song, S Devic, ...
International Journal of Radiation Oncology* Biology* Physics 89 (3), 666-673, 2014
572014
Volumetric changes of the anterolateral thigh free flap following adjuvant radiotherapy in total parotidectomy reconstruction
KM Higgins, BM Erovic, A Ravi, R Yeung, JW Lee, C Yao, DJ Enepekides
The Laryngoscope 122 (4), 767-772, 2012
552012
Phase 1-2 study of stereotactic ablative radiotherapy including regional lymph node irradiation in patients with high-risk prostate cancer (SATURN): Early toxicity and quality …
HB Musunuru, L D'Alimonte, M Davidson, L Ho, P Cheung, D Vesprini, ...
International Journal of Radiation Oncology* Biology* Physics 102 (5), 1438-1447, 2018
512018
Pattern of relapse and dose received by the recurrent intraprostatic nodule in low-to intermediate-risk prostate cancer treated with single fraction 19 Gy high-dose-rate …
LC Mendez, A Ravi, H Chung, CL Tseng, M Wronski, M Paudel, ...
Brachytherapy 17 (2), 291-297, 2018
462018
Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: A systematic review of technique, local control and toxicities
LC Mendez, Y Weiss, D D'Souza, A Ravi, L Barbera, E Leung
Radiotherapy and Oncology 123 (2), 312-318, 2017
462017
Two StereoTactic ablative radiotherapy treatments for localized prostate cancer (2STAR): Results from a prospective clinical trial
Y Alayed, P Cheung, W Chu, H Chung, M Davidson, A Ravi, J Helou, ...
Radiotherapy and Oncology 135, 86-90, 2019
452019
Clinical evaluation of an endorectal immobilization system for use in prostate hypofractionated Stereotactic Ablative Body Radiotherapy (SABR)
A Nicolae, M Davidson, H Easton, J Helou, H Musunuru, A Loblaw, A Ravi
Radiation oncology 10, 1-8, 2015
452015
Permanent breast seed implant dosimetry quality assurance
BM Keller, A Ravi, R Sankreacha, JP Pignol
International Journal of Radiation Oncology* Biology* Physics 83 (1), 84-92, 2012
452012
SABR in high-risk prostate cancer: outcomes from 2 prospective clinical trials with and without elective nodal irradiation
Y Alayed, P Cheung, D Vesprini, S Liu, W Chu, H Chung, HB Musunuru, ...
International Journal of Radiation Oncology* Biology* Physics 104 (1), 36-41, 2019
442019
Predictive parameters of symptomatic hematochezia following 5-fraction gantry-based SABR in prostate cancer
HB Musunuru, M Davidson, P Cheung, D Vesprini, S Liu, H Chung, ...
International Journal of Radiation Oncology* Biology* Physics 94 (5), 1043-1051, 2016
422016
Direction modulated brachytherapy for treatment of cervical cancer. II: Comparative planning study with intracavitary and intracavitary–interstitial techniques
DY Han, H Safigholi, A Soliman, A Ravi, E Leung, DJ Scanderbeg, Z Liu, ...
International Journal of Radiation Oncology* Biology* Physics 96 (2), 440-448, 2016
402016
The system can't perform the operation now. Try again later.
Articles 1–20